Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedEnrollment is updated to no longer looking for participants, signaling that recruitment has ended. The revision history now shows a new tag v3.6.0, replacing the previous v3.5.5 tag.SummaryDifference0.4%

- Check17 days agoChange DetectedThe footer now shows Revision: v3.5.5 instead of Revision: v3.5.4, indicating a newer site version was deployed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history now shows a new release entry Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a minor site update to ClinicalTrials.gov rather than changes to trial data.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer’s revision/version indicator was updated from 3.5.2 to 3.5.3 for the ClinicalTrials.gov site interface.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check95 days agoChange DetectedThe Record History shows the addition of revision v3.5.0 and the removal of revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.